Open AccessLB4. Efficacy and Safety of Cefiderocol vs. High-Dose Meropenem in Patients with Nosocomial Pneumonia—Results of a Phase 3, Randomized, Multicenter, Double-Blind, Non-Inferiority Study
Author(s) -
Richard G. Wunderink,
Yuko Matsunaga,
Mari Ari,
Mari Ariyasu,
Roger Echols,
Anju Me,
Tsutae Den Nagata
Publication year - 2019
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofz415.2487
Subject(s) - medicine , clinical endpoint , pneumonia , population , randomized controlled trial , confidence interval , linezolid , bacteremia , meropenem , carbapenem , adverse effect , antibiotics , antibiotic resistance , microbiology and biotechnology , bacteria , environmental health , vancomycin , biology , genetics , staphylococcus aureus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom